t(8;21) and inv(16), collectively termed core binding factor (CBF) AML, represent the most common cytogenetic subgroup in pediatric AML accounting for 20–25% of cases [1, 10••, 11]. The gene discussed is CEBPZ; the disease is acute myeloid leukemia.